Phage genetic engineering using CRISPR–Cas systems

Viruses

Volumn 10, Issue 6, 2018, Pages

  Hatoum Aslan, Asma ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

Bacteriophage; CRISPR Cas; Genome editing; Phage genetics

Indexed keywords

PALINDROMIC DNA;

BACTERIOPHAGE; BIOGENESIS; CRISPR CAS SYSTEM; DATA BASE; DNA FLANKING REGION; ESCHERICHIA COLI; GENE EDITING; GENE PRODUCT; GENETIC ENGINEERING; IMMUNE SYSTEM; LACTOCOCCUS LACTIS; NONHUMAN; NONSENSE MUTATION; PLASMID; POINT MUTATION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS THERMOPHILUS; VIBRIO CHOLERAE; ARCHAEON; BACTERIUM; GENETICS; PROCEDURES; VIROLOGY;

ARCHAEA; BACTERIA; BACTERIOPHAGES; CRISPR-CAS SYSTEMS; GENETIC ENGINEERING;

EID: 85049201525     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v10060335     Document Type: Review

References (76)

1. Hatfull, G.F. Dark Matter of the Biosphere: The Amazing World of Bacteriophage Diversity. J. Virol. 2015, 89, 8107–8110. [CrossRef] [PubMed]
2. Brüssow, H.; Hendrix, R.W. Phage Genomics: Small Is Beautiful. Cell 2002, 108, 13–16. [CrossRef]
3. Comeau, M.; Hatfull, G.F.; Krisch, H.M.; Lindell, D.; Mann, N.H.; Prangishvili, D. Exploring the Prokaryotic Virosphere. Res. Microbiol. 2008, 159, 306–313. [CrossRef] [PubMed]
4. Bergh, O.; Børsheim, K.Y.; Bratbak, G.; Heldal, M. High Abundance of Viruses Found in Aquatic Environments. Nature 1989, 340, 467–468. [CrossRef] [PubMed]
5. Breitbart, M.; Rohwer, F. Here a Virus, There a Virus, Everywhere the Same Virus? Trends Microbiol. 2005, 13, 278–284. [CrossRef] [PubMed]
6. Brüssow, H.; Canchaya, C.; Hardt, W.; Bru, H. Phages and the Evolution of Bacterial Pathogens: From Genomic Rearrangements to Lysogenic Conversion. Microbiol. Mol. Biol. Rev. 2004, 68, 560–602. [CrossRef] [PubMed]
7. Waldor, M.K.; Mekalanos, J.J. Lysogenic Conversion by a Filamentous Phage Encoding Cholera Toxin. Science 1996, 272, 1910–1914. [CrossRef] [PubMed]
8. Zinder, N.D.; Lederberg, J. Genetic Exchange in Salmonella. J. Bacteriol. 1952, 64, 679–699. [PubMed]
9. Suttle, C.A. Marine Viruses—Major Players in the Global Ecosystem. Nat. Rev. Microbiol. 2007, 5, 801–812. [CrossRef] [PubMed]
10. Reche, I.; D’Orta, G.; Mladenov, N.; Winget, D.M.; Suttle, C.A. Deposition Rates of Viruses and Bacteria above the Atmospheric Boundary Layer. ISME J. 2018, 12, 1154–1162. [CrossRef] [PubMed]
11. Van Wezenbeek, P.M.; Hulsebos, T.J.; Schoenmakers, J.G. Nucleotide Sequence of the Filamentous Bacteriophage M13 DNA Genome: Comparison with Phage Fd. Gene 1980, 11, 129–148. [CrossRef]
12. Krisch, H.M.; Comeau, A.M. The Immense Journey of Bacteriophage T4-From d’Hérelle to Delbrück and Then to Darwin and beyond. Res. Microbiol. 2008, 159, 314–324. [CrossRef] [PubMed]
13. Casjens, S.R.; Hendrix, R.W. Bacteriophage Lambda: Early Pioneer and Still Relevant. Virology 2015, 479–480, 310–330. [CrossRef] [PubMed]
14. Salmond, G.P.C.; Fineran, P.C. A Century of the Phage: Past, Present and Future. Nat. Rev. Microbiol. 2015, 13, 777–786. [CrossRef] [PubMed]
15. Hershey, A.D.; Chase, M. Independent Functions of Viral Protein and Nucleic Acid in Growth of Bacteriophage. J. Gen. Physiol. 1952, 36, 39–56. [CrossRef] [PubMed]
16. Brenner, S.; Jacob, F.; Meselson, M. An Unstable Intermediate Carrying Information from Genes to Ribosomes for Protein Synthesis. Nature 1961, 190, 576–581. [CrossRef] [PubMed]
17. Crick, F.H.C.; Barnett, L.; Brenner, S.; Watts-Tobin, R.J. General Nature of the Genetic Code for Proteins. Nature 1961, 192, 1227–1232. [CrossRef] [PubMed]
18. Barrangou, R.; Fremaux, C.; Deveau, H.; Richards, M.; Boyaval, P.; Moineau, S.; Romero, D.A.; Horvath, P. CRISPR Provides Acquired Resistance against Viruses in Prokaryotes. Science 2007, 315, 1709–1712. [CrossRef] [PubMed]
19. Doudna, J.A.; Charpentier, E. The New Frontier of Genome Engineering with CRISPR-Cas9. Science 2014, 346, 1258096. [CrossRef] [PubMed]
20. Twort, F.W. An Investigation on the Nature of Ultra-Microscopic Viruses. Lancet 1915, 186, 1241–1243. [CrossRef]
21. D’Herelle, F. Sur Un Microbe Invisible Antagoniste Des Bacilles Dysentériques. CR Acad. Sci. Paris 1917, 165, 373–375.
22. Miller, E.S.; Kutter, E.; Mosig, G.; Arisaka, F.; Kunisawa, T.; Rüger, W. Bacteriophage T4 Genome. Microbiol. Mol. Biol. Rev. 2003, 67, 86–156. [CrossRef] [PubMed]
23. Pope, W.H.; Bowman, C.A.; Russell, D.A.; Jacobs-Sera, D.; Asai, D.J.; Cresawn, S.G.; Jacobs, W.R.; Hendrix, R.W.; Lawrence, J.G.; Hatfull, G.F. Whole Genome Comparison of a Large Collection of Mycobacteriophages Reveals a Continuum of Phage Genetic Diversity. eLife 2015, 4, e06416. [CrossRef] [PubMed]
24. Henn, M.R.; Sullivan, M.B.; Stange-Thomann, N.; Osburne, M.S.; Berlin, A.M.; Kelly, L.; Yandava, C.; Kodira, C.; Zeng, Q.; Weiand, M.; et al. Analysis of High-Throughput Sequencing and Annotation Strategies for Phage Genomes. PLoS ONE 2010, 5, e9083. [CrossRef] [PubMed]
25. Rihtman, B.; Meaden, S.; Clokie, M.R.J.; Koskella, B.; Millard, A.D. Assessing Illumina Technology for the High-Throughput Sequencing of Bacteriophage Genomes. PeerJ 2016, 4, e2055. [CrossRef] [PubMed]
26. Pires, D.P.; Cleto, S.; Sillankorva, S.; Azeredo, J.; Lu, T.K. Genetically Engineered Phages: A Review of Advances over the Last Decade. Microbiol. Mol. Biol. Rev. 2016, 80, 523–543. [CrossRef] [PubMed]
27. Loessner, M.J.; Rees, C.E.; Stewart, G.S.; Scherer, S. Construction of Luciferase Reporter Bacteriophage A511::luxAB for Rapid and Sensitive Detection of Viable Listeria Cells. Appl. Environ. Microbiol. 1996, 62, 1133–1140. [PubMed]
28. Martel, B.; Moineau, S. CRISPR-Cas: An Efficient Tool for Genome Engineering of Virulent Bacteriophages. Nucleic Acids Res. 2014, 42, 9504–9513. [CrossRef] [PubMed]
29. Chan, L.Y.; Kosuri, S.; Endy, D. Refactoring Bacteriophage T7. Mol. Syst. Biol. 2005, 1. [CrossRef] [PubMed]
30. Marinelli, L.J.; Piuri, M.; Swigoňová, Z.; Balachandran, A.; Oldfield, L.M.; van Kessel, J.C.; Hatfull, G.F. BRED: A Simple and Powerful Tool for Constructing Mutant and Recombinant Bacteriophage Genomes. PLoS ONE 2008, 3, e3957. [CrossRef] [PubMed]
31. Ando, H.; Lemire, S.; Pires, D.P.; Lu, T.K. Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing. Cell Syst. 2015, 1, 187–196. [CrossRef] [PubMed]
32. Kilcher, S.; Studer, P.; Muessner, C.; Klumpp, J.; Loessner, M.J. Cross-Genus Rebooting of Custom-Made, Synthetic Bacteriophage Genomes in L-Form Bacteria. Proc. Natl. Acad. Sci. USA 2018, 115, 567–572. [CrossRef] [PubMed]
33. Kiro, R.; Shitrit, D.; Qimron, U. Efficient Engineering of a Bacteriophage Genome Using the Type I-E CRISPR-Cas System. RNA Biol. 2014, 11, 42–44. [CrossRef] [PubMed]
34. Box, A.M.; McGuffie, M.J.; O’Hara, B.J.; Seed, K.D. Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering. J. Bacteriol. 2016, 198, 578–590. [CrossRef] [PubMed]
35. Lemay, M.-L.; Tremblay, D.M.; Moineau, S. Genome Engineering of Virulent Lactococcal Phages Using CRISPR-Cas9. ACS Synth. Biol. 2017, 6, 1351–1358. [CrossRef] [PubMed]
36. Bari, S.M.N.; Walker, F.C.; Cater, K.; Aslan, B.; Hatoum-Aslan, A. Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10. ACS Synth. Biol. 2017, 6, 2316–2325. [CrossRef] [PubMed]
37. Tao, P.; Wu, X.; Tang, W.-C.; Zhu, J.; Rao, V. Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9. ACS Synth. Biol. 2017, 6, 1952–1961. [CrossRef] [PubMed]
38. Grissa, I.; Vergnaud, G.; Pourcel, C. The CRISPRdb Database and Tools to Display CRISPRs and to Generate Dictionaries of Spacers and Repeats. BMC Bioinform. 2007, 8, 172. [CrossRef] [PubMed]
39. Godde, J.S.; Bickerton, A. The Repetitive DNA Elements Called CRISPRs and Their Associated Genes: Evidence of Horizontal Transfer among Prokaryotes. J. Mol. Evol. 2006, 62, 718–729. [CrossRef] [PubMed]
40. Haft, D.H.; Selengut, J.; Mongodin, E.F.; Nelson, K.E. A Guild of 45 CRISPR-Associated (Cas) Protein Families and Multiple CRISPR/Cas Subtypes Exist in Prokaryotic Genomes. PLoS Comput. Biol. 2005, 1, e60. [CrossRef] [PubMed]
41. Brouns, S.J.J.; Jore, M.M.; Lundgren, M.; Westra, E.R.; Slijkhuis, R.J.H.; Snijders, A.P.L.; Dickman, M.J.; Makarova, K.S.; Koonin, E.V.; van der Oost, J. Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes. Science 2008, 321, 960–964. [CrossRef] [PubMed]
42. Makarova, K.S.; Wolf, Y.I.; Alkhnbashi, O.S.; Costa, F.; Shah, S.A.; Saunders, S.J.; Barrangou, R.; Brouns, S.J.J.; Charpentier, E.; Haft, D.H.; et al. An Updated Evolutionary Classification of CRISPR-Cas Systems. Nat. Rev. Microbiol. 2015, 13, 722–736. [CrossRef] [PubMed]
43. Koonin, E.V.; Makarova, K.S.; Zhang, F. Diversity, Classification and Evolution of CRISPR-Cas Systems. Curr. Opin. Microbiol. 2017, 37, 67–78. [CrossRef] [PubMed]
44. Sinkunas, T.; Gasiunas, G.; Fremaux, C.; Barrangou, R.; Horvath, P.; Siksnys, V. Cas3 Is a Single-Stranded DNA Nuclease and ATP-Dependent Helicase in the CRISPR/Cas Immune System. EMBO J. 2011, 30, 1335–1342. [CrossRef] [PubMed]
45. Beloglazova, N.; Petit, P.; Flick, R.; Brown, G.; Savchenko, A.; Yakunin, A.F. Structure and Activity of the Cas3 HD Nuclease MJ0384, an Effector Enzyme of the CRISPR Interference. EMBO J. 2011, 30, 4616–4627. [CrossRef] [PubMed]
46. Westra, E.R.; van Erp, P.B.G.; Künne, T.; Wong, S.P.; Staals, R.H.J.; Seegers, C.L.C.; Bollen, S.; Jore, M.M.; Semenova, E.; Severinov, K.; et al. CRISPR Immunity Relies on the Consecutive Binding and Degradation of Negatively Supercoiled Invader DNA by Cascade and Cas3. Mol. Cell 2012, 46, 595–605. [CrossRef] [PubMed]
47. Jackson, R.N.; Golden, S.M.; van Erp, P.B.G.; Carter, J.; Westra, E.R.; Brouns, S.J.J.; van der Oost, J.; Terwilliger, T.C.; Read, R.J.; Wiedenheft, B. Crystal Structure of the CRISPR RNA–Guided Surveillance Complex from Escherichia coli. Science 2014, 345, 1473–1479. [CrossRef] [PubMed]
48. Mulepati, S.; Héroux, A.; Bailey, S. Crystal Structure of a CRISPR RNA–Guided Surveillance Complex Bound to a ssDNA Target. Science 2014, 345, 1479–1484. [CrossRef] [PubMed]
49. Deveau, H.; Barrangou, R.; Garneau, J.E.; Labonté, J.; Fremaux, C.; Boyaval, P.; Romero, D.A.; Horvath, P.; Moineau, S. Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus. J. Bacteriol. 2008, 190, 1390–1400. [CrossRef] [PubMed]
50. Mojica, F.J.M.; Díez-Villaseñor, C.; García-Martínez, J.; Almendros, C. Short Motif Sequences Determine the Targets of the Prokaryotic CRISPR Defence System. Microbiology 2009, 155, 733–740. [PubMed]
51. Semenova, E.; Jore, M.M.; Datsenko, K.A.; Semenova, A.; Westra, E.R.; Wanner, B.; van der Oost, J.; Brouns, S.J.J.; Severinov, K. Interference by Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNA Is Governed by a Seed Sequence. Proc. Natl. Acad. Sci. USA 2011, 108, 10098–10103. [CrossRef] [PubMed]
52. Wiedenheft, B.; van Duijn, E.; Bultema, J.B.; Waghmare, S.; Zhou, K.; Barendregt, A.; Westphal, W.; Heck, A.J.R.; Boekema, E.J.; Dickman, M.J.; et al. RNA-Guided Complex from a Bacterial Immune System Enhances Target Recognition through Seed Sequence Interactions. Proc. Natl. Acad. Sci. USA 2011, 108, 10092–10097. [CrossRef] [PubMed]
53. Manor, M.; Qimron, U. Selection of Genetically Modified Bacteriophages Using the CRISPR-Cas System. Bio-Protocol 2017, 7. [CrossRef] [PubMed]
54. Chylinski, K.; Makarova, K.S.; Charpentier, E.; Koonin, E.V. Classification and Evolution of Type II CRISPR-Cas Systems. Nucleic Acids Res. 2014, 42, 6091–6105. [CrossRef] [PubMed]
55. Deltcheva, E.; Chylinski, K.; Sharma, C.M.; Gonzales, K.; Chao, Y.; Pirzada, Z.A.; Eckert, M.R.; Vogel, J.; Charpentier, E. CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III. Nature 2011, 471, 602–607. [CrossRef] [PubMed]
56. Garneau, J.E.; Dupuis, M.È.; Villion, M.; Romero, D.A.; Barrangou, R.; Boyaval, P.; Fremaux, C.; Horvath, P.; Magadán, A.H.; Moineau, S. The CRISPR/cas Bacterial Immune System Cleaves Bacteriophage and Plasmid DNA. Nature 2010, 468, 67–71. [CrossRef] [PubMed]
57. Sapranauskas, R.; Gasiunas, G.; Fremaux, C.; Barrangou, R.; Horvath, P.; Siksnys, V. The Streptococcus thermophilus CRISPR/Cas System Provides Immunity in Escherichia Coli. Nucleic Acids Res. 2011, 39, 9275–9282. [CrossRef] [PubMed]
58. Jiang, W.; Bikard, D.; Cox, D.; Zhang, F.; Marraffini, L.A. CRISPR-Assisted Editing of Bacterial Genomes. Nat. Biotechnol. 2013, 31, 233–239. [CrossRef] [PubMed]
59. Marraffini, L.A.; Sontheimer, E.J. CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA. Science 2008, 322, 1843–1845. [CrossRef] [PubMed]
60. Marraffini, L.A.; Sontheimer, E.J. Self vs. Non-Self Discrimination during CRISPR RNA-Directed Immunity. Nature 2010, 463, 568–571. [CrossRef] [PubMed]
61. Hatoum-Aslan, A.; Maniv, I.; Marraffini, L.A. Mature Clustered, Regularly Interspaced, Short Palindromic Repeats RNA (crRNA) Length Is Measured by a Ruler Mechanism Anchored at the Precursor Processing Site. Proc. Natl. Acad. Sci. USA 2011, 108, 21218–21222. [CrossRef] [PubMed]
62. Hatoum-Aslan, A.; Maniv, I.; Samai, P.; Marraffini, L.A. Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System. J. Bacteriol. 2014, 196, 310–317. [CrossRef] [PubMed]
63. Walker, F.C.; Chou-Zheng, L.; Dunkle, J.A.; Hatoum-Aslan, A. Molecular Determinants for CRISPR RNA Maturation in the Cas10—Csm Complex and Roles for Non-Cas Nucleases. Nucleic Acids Res. 2017, 45, 2112–2123. [CrossRef] [PubMed]
64. Hatoum-Aslan, A.; Samai, P.; Maniv, I.; Jiang, W.; Marraffini, L.A. A Ruler Protein in a Complex for Antiviral Defense Determines the Length of Small Interfering CRISPR RNAs. J. Biol. Chem. 2013, 288, 27888–27897. [CrossRef] [PubMed]
65. Goldberg, G.W.; Jiang, W.; Bikard, D.; Marraffini, L.A. Conditional Tolerance of Temperate Phages via Transcription-Dependent CRISPR-Cas Targeting. Nature 2014, 514, 633–637. [CrossRef] [PubMed]
66. Samai, P.; Pyenson, N.; Jiang, W.; Goldberg, G.W.; Hatoum-Aslan, A.; Marraffini, L.A. Co-Transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity. Cell 2015, 161, 1164–1174. [CrossRef] [PubMed]
67. Jiang, W.; Samai, P.; Marraffini, L.A. Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity. Cell 2016, 164, 710–721. [CrossRef] [PubMed]
68. Kazlauskiene, M.; Kostiuk, G.; Venclovas, Č.; Tamulaitis, G.; Siksnys, V. A Cyclic Oligonucleotide Signaling Pathway in Type III CRISPR-Cas Systems. Science 2017, 357, 605–609. [CrossRef] [PubMed]
69. Niewoehner, O.; Garcia-Doval, C.; Rostøl, J.T.; Berk, C.; Schwede, F.; Bigler, L.; Hall, J.; Marraffini, L.A.; Jinek, M. Type III CRISPR–Cas Systems Produce Cyclic Oligoadenylate Second Messengers. Nature 2017, 548, 543–548. [CrossRef] [PubMed]
70. Maniv, I.; Jiang, W.; Bikard, D.; Marraffini, L.A. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity. J. Bacteriol. 2016, 198, 941–950. [CrossRef] [PubMed]
71. Pyenson, N.C.; Gayvert, K.; Varble, A.; Elemento, O.; Marraffini, L.A. Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape. Cell Host Microbe 2017, 22, 343–353. [CrossRef] [PubMed]
72. Cater, K.; Dandu, V.S.; Bari, S.M.N.; Lackey, K.; Everett, G.F.K.; Hatoum-Aslan, A. A Novel Staphylococcus Podophage Encodes a Unique Lysin with Unusual Modular Design. mSphere 2017, 2. [CrossRef] [PubMed]
73. Vandersteegen, K.; Mattheus, W.; Ceyssens, P.J.; Bilocq, F.; de Vos, D.; Pirnay, J.P.; Noben, J.P.; Merabishvili, M.; Lipinska, U.; Hermans, K.; et al. Microbiological and Molecular Assessment of Bacteriophage ISP for the Control of Staphylococcus aureus. PLoS ONE 2011, 6, e24418. [CrossRef] [PubMed]
74. Bondy-Denomy, J.; Pawluk, A.; Maxwell, K.L.; Davidson, A.R. Bacteriophage Genes that Inactivate the CRISPR/Cas Bacterial Immune System. Nature 2013, 493, 429–432. [CrossRef] [PubMed]
75. Pawluk, A.; Bondy-Denomy, J.; Cheung, V.H.W.; Maxwell, K.L.; Davidson, R. A New Group of Phage Anti-CRISPR Genes Inhibits the Type I-E CRISPR-Cas System of Pseudomonas aeruginosa. mBio 2014, 5. [CrossRef] [PubMed]
76. Pawluk, A.; Amrani, N.; Zhang, Y.; Garcia, B.; Hidalgo-Reyes, Y.; Lee, J.; Edraki, A.; Shah, M.; Sontheimer, E.J.; Maxwell, K.L.; et al. Naturally Occurring Off-Switches for CRISPR-Cas9. Cell 2016, 167, 1829–1838. [CrossRef] [PubMed]